Drug intelligence / Profile preview

experimental probiotic 2

Development stage: Preclinical
Lead developer: Mead Johnson Nutrition
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Experimental probiotic 2 is an investigational probiotic being studied for its effects as a bioactive ingredient in children's cow's milk-based formulas. Developed by Mead Johnson Nutrition, it is being investigated for its impact on blood serum markers, specifically changes in leukocyte populations, suggesting a role in immune system modulation.

Beyond the preview

Go deeper on experimental probiotic 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on experimental probiotic 2.

Explore the full profile